Pro-inflammatory cytokine production pathway

The "pro-inflammatory cytokine production pathway" is not a single molecule or receptor, but rather refers to the complex network of cellular processes that lead to the synthesis and release of pro-inflammatory cytokines. These small secreted proteins—including interleukin‑1 beta (IL‑1β), interleukin‑6 (IL‑6), tumor necrosis factor alpha (TNF‑α), interferon gamma (IFNγ), and others—are produced primarily by immune cells such as macrophages and T helper cells in response to pathogens or tissue injury. They act via binding to specific cell surface receptors on various target cells throughout the body, triggering inflammation and coordinating immune responses. Dysregulation or chronic overproduction of these pathways contributes significantly to inflammatory diseases including autoimmune disorders, infections with severe systemic inflammation ("cytokine storm"), cancer progression, cardiovascular diseases, neurodegenerative conditions, and more. Therapeutic interventions often focus on blocking key molecules within this network—such as using monoclonal antibodies against TNF-alpha or IL–6—but there is no single "pro-inflammatory cytokine production pathway" protein that serves as a direct drug target.

Other names

Proinflammatory cytokine pathwayInflammatory cytokine signalingCytokine storm pathway (context-dependent)